IgG4 immune response in Churg–Strauss syndrome

Published on Mar 1, 2012in Annals of the Rheumatic Diseases16.102
· DOI :10.1136/ARD.2011.155382
Augusto Vaglio42
Estimated H-index: 42
(University of Parma),
Johanna D Strehl13
Estimated H-index: 13
+ 10 AuthorsJochen Zwerina60
Estimated H-index: 60
Sources
Abstract
Objective T-helper type 2 responses are crucial in Churg–Strauss syndrome (CSS) and may enhance the production of IgG4 antibodies. The authors assessed the IgG4 immune response in CSS patients. Methods The authors included 46 consecutive patients with CSS (24 with active and 22 with quiescent disease), 26 with granulomatosis with polyangiitis (GPA, Wegener9s), 25 with atopic asthma and 20 healthy controls and determined serum IgG, IgM, IgA, IgE and IgG subclass levels. Tissue infiltration by IgG4 plasma cells was assessed in nine patients with CSS, 10 with GPA, 22 with chronic sinusitis (11 with and 11 without eosinophilia). Results IgG4 levels were markedly higher in active CSS patients than in controls (p −5 and p=6×10 −4 , respectively). Tissue analysis did not show an increased IgG4 plasma cell infiltration in CSS biopsies compared with control groups. Conclusions Serum IgG4 levels are markedly elevated in active CSS and correlate with the number of organ manifestations and disease activity.
Download
📖 Papers frequently viewed together
2,774 Citations
60 Citations
404 Citations
References20
Newest
#1Jochen Zwerina (Bernhard Nocht Institute for Tropical Medicine)H-Index: 60
#2Christian Bach (Bernhard Nocht Institute for Tropical Medicine)H-Index: 13
Last. Augusto Vaglio (Bernhard Nocht Institute for Tropical Medicine)H-Index: 42
view all 14 authors...
Objectives. To determine the potential of eotaxin-3 as a diagnostic marker for active disease and genetic susceptibility factor for Churg-Strauss syndrome (CSS). Methods. A total of 37 patients with active, relapsed or inactive CSS, 123 healthy controls and 138 disease controls were studied. Clinical data were collected and serum levels of eotaxin-3 were determined. Ex vivo stability of eotaxin-3 in serum samples was tested. Furthermore, the association of single nucleotide polymorphisms (SNPs) ...
66 CitationsSource
#1Rodrigo Cartin-Ceba (Mayo Clinic)H-Index: 31
#2Karina A. Keogh (Mayo Clinic)H-Index: 22
Last. Fernando C. Fervenza (Mayo Clinic)H-Index: 63
view all 5 authors...
Introduction. Churg–Strauss syndrome (CSS) is a small vessel systemic vasculitis associated with asthma and eosinophilia that causes glomerulonephritis (GN) in ∼25% of patients. Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that depletes B cells and is effective in numerous autoimmune diseases including antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. We aim to evaluate the safety and efficacy of RTX in inducing remission of renal disease activity in patients with ...
80 CitationsSource
#1Ravi Suppiah (University of Oxford)H-Index: 15
#2Chetan Mukhtyar (NNUH: Norfolk and Norwich University Hospital)H-Index: 20
Last. Raashid Luqmani (University of Oxford)H-Index: 56
view all 18 authors...
Objective. Assessment of disease activity in vasculitis can be achieved using the BVAS, a clinical checklist of relevant symptoms, signs and features of active disease. The aim of this study was to revalidate the BVAS version 3 (BVAS v. 3) in a cohort of patients with systemic vasculitis. Methods. A total of 238 patients with vasculitis from seven countries in Europe were evaluated at a single time point. Spearman’s correlation coefficients were calculated between BVAS v. 3 scores, vasculitis ac...
62 CitationsSource
#1Johanna D Strehl (FAU: University of Erlangen-Nuremberg)H-Index: 13
#2Arndt HartmannH-Index: 81
Last. Abbas AgaimyH-Index: 45
view all 3 authors...
Background IgG4-related systemic fibrosclerosis is a recently defined disorder characterised by a diffuse or tumefactive inflammatory reaction rich in IgG4-positive plasma cells associated with sclerosis and obliterative phlebitis. Although characteristic histopathological features are essential for the diagnosis of these disorders, to date there exists no consensus regarding the cut-off values used to define a ‘significant IgG4-positive plasma cell count,’ and data regarding the distribution of...
254 CitationsSource
Purpose of reviewThe spectrum of IgG4-related systemic disease (IgG4-RSD) continues to widen. At most of the sites involved by this condition, the clinical presentation can mimic neoplasm. Pathologic assessment of small biopsies can be critical to proper management. This review summarizes the histol
77 CitationsSource
#1Ajay Nirula (Biogen Idec)H-Index: 12
#2Scott M GlaserH-Index: 1
Last. Frederick R TayloraH-Index: 1
view all 4 authors...
Purpose of reviewRecent descriptions of the group of clinical disorders collectively defined as IgG4-related systemic disease (IgG4-RSD) have prompted this review of the unique biology of the IgG4 antibody. This article will discuss IgG4 structure and function, the unique phenomenon of half-antibody
211 CitationsSource
Purpose of reviewTo summarize the existing knowledge of various clinical presentations of IgG4-related systemic disease (IgG4-RSD) and to review the evolving list of organs affected by IgG4-RSD.Recent findingsThe term IgG4-RSD encompasses a variety of clinical entities once regarded as being entirel
223 CitationsSource
#1Tomáš Dallos (Comenius University in Bratislava)H-Index: 12
#2Gisela Ruiz Heiland (FAU: University of Erlangen-Nuremberg)H-Index: 7
Last. Jochen Zwerina (FAU: University of Erlangen-Nuremberg)H-Index: 60
view all 11 authors...
Objective. Churg-Strauss syndrome (CSS) is a Th2-mediated systemic vasculitis characterized by eosinophilic infiltration, blood eosinophilia, and high IgE levels. CCL17/thymus and activation–regulated chemokine (TARC) is a chemokine responsible for the recruitment of Th2 cells. This study was undertaken to explore a possible role of CCL17/TARC in CSS. Methods. CCL17/TARC levels in serum from patients with active or inactive CSS, hypereosinophilic syndrome, systemic small-vessel vasculitis other ...
78 CitationsSource
#1Motohisa Yamamoto (Sapporo Medical University)H-Index: 35
#2Hiroki Takahashi (Sapporo Medical University)H-Index: 51
Last. Yasuhisa Shinomura (Sapporo Medical University)H-Index: 66
view all 9 authors...
Objective Mikulicz's disease (MD) is characterized by symmetrical and persistent enlargement of the lacrimal and salivary glands. Recently it has been categorized as an 'Ig (immunoglobulin) G4-related disease.' It presents with elevated serum levels of IgG4 and abundant infiltration of IgG4-bearing plasmacytes in involved organs. Allergic symptoms are often observed in patients with IgG4-related disease. On the other hand, allergic diseases are often complicated with Churg-Strauss syndrome (CSS)...
115 CitationsSource
#1Yoh Zen (University of Cambridge)H-Index: 69
#2Manabu OnoderaH-Index: 10
Last. Yasuni NakanumaH-Index: 87
view all 16 authors...
The possible involvement of immunoglobulin G4 (IgG4) in the pathogenesis of idiopathic sclerosing lesions has been suggested. In this study, a clinicopathologic analysis was performed to reveal characteristics of retroperitoneal fibrosis relating to IgG4. The study involved 17 patients with retroperitoneal fibrosis. Immunohistochemistry revealed numerous IgG4-positive plasma cell infiltrates in 10 cases (IgG4-related), but only a few positive cells in 7 cases (non-IgG4-related). All patients wit...
314 CitationsSource
Cited By122
Newest
#1Filippo Fagni (UniFI: University of Florence)H-Index: 1
#2Federica Bello (UniFI: University of Florence)H-Index: 1
Last. Giacomo Emmi (UniFI: University of Florence)H-Index: 27
view all 3 authors...
Eosinophilic Granulomatosis with Polyangiitis (EGPA) is a rare multisystemic disease classified both amongst hypereosinophilic disorders and ANCA-associated vasculitis. Vessel inflammation and eosinophilic proliferation are the hallmarks of the disease and main effectors of organ damage. Two distinct disease phenotypes have classically been described according to ANCA-status: the ANCA-negative subset with eosinophil-driven manifestation and the ANCA-positive one with vasculitic manifestations. A...
Source
#1Paride FenaroliH-Index: 4
#2Federica MaritatiH-Index: 13
Last. Augusto Vaglio (UniFI: University of Florence)H-Index: 42
view all 3 authors...
PURPOSE OF THE REVIEW We aim to review the most relevant diagnostic features and treatment options of retroperitoneal fibrosis, in order to provide a useful guide for clinical practice. RECENT FINDINGS The recent literature highlights the role of imaging studies such as computed tomography, magnetic resonance imaging and positron emission tomography as useful tools for the diagnosis of retroperitoneal fibrosis, with retroperitoneal biopsy being reserved to atypical cases. The treatment approach ...
1 CitationsSource
#1Mitsuhiro Akiyama (Keio: Keio University)H-Index: 12
#2Yuko Kaneko (Keio: Keio University)H-Index: 20
Last. Tsutomu Takeuchi (Keio: Keio University)H-Index: 68
view all 3 authors...
Abstract Objective We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). Methods We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EGPA. Results We identified a total of 171 patients; most of the patients had refractory or relapsing disease, whereas 14 patients were newly diagnosed with EGPA. Rituximab w...
1 CitationsSource
#1Andreas KronbichlerH-Index: 21
#2Erica L Bettac (Washington State University Vancouver)H-Index: 1
Source
#1Sergey MoiseevH-Index: 13
#2Xavier Bossuyt (Katholieke Universiteit Leuven)H-Index: 45
Last. Jan Willem Cohen Tervaert (UM: Maastricht University)H-Index: 58
view all 27 authors...
An international consensus on anti-neutrophil cytoplasm antibodies (ANCA) testing in eosinophilic granulomatosis with polyangiitis (EGPA) is presented. ANCA, specific for myeloperoxidase (MPO), can be detected in 30-35% of EGPA patients. MPO-ANCA should be tested with antigen-specific immunoassays in any patient with eosinophilic asthma and clinical features suggesting EGPA, including constitutional symptoms, purpura, polyneuropathy, unexplained heart, gastrointestinal or kidney disease, and/or ...
5 CitationsSource
#1John P. Marinelli (Mayo Clinic)H-Index: 7
#2Chiara Marvisi (University of Modena and Reggio Emilia)H-Index: 4
Last. Matthew L. Carlson (Mayo Clinic)H-Index: 26
view all 10 authors...
OBJECTIVE: IgG4-related disease (IgG4-RD) is a recently recognized disease characterized by fibroinflammatory infiltrates rich in IgG4+ plasma cells that can present as isolated tumor-like lesions of the head and neck. The objective of the current study was to describe the cranial base manifestations of IgG4-RD. METHODS: Review of all cases at three tertiary-referral centers since disease description in 2003. RESULTS: Eleven patients were identified at a median age at presentation of 58 years (I...
3 CitationsSource
#1Mitsuhiro Akiyama (Keio: Keio University)H-Index: 12
#2Yuko Kaneko (Keio: Keio University)H-Index: 20
Last. Tsutomu Takeuchi (Keio: Keio University)H-Index: 68
view all 3 authors...
We read the paper by Vaglio et al in your journal with great interest.1 They reported that patients with eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome, showed high serum IgG4 levels, correlating with disease activity and the extent of organ involvement.1 Since then, the association between EGPA and IgG4-related disease has been discussed by researchers.2–4 EGPA is one of the systemic vasculitis and is typically preceded by bronchial asthma, alle...
3 CitationsSource